Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in ZYME — Zymeworks Inc.

CIK 902219 Boston, MA
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,875,765
-$597,031 QoQ
Shares Held
110,014
-20.7% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 202 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 70% None 30%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. ZYME ranks #102 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,247,658 $1,613,209,155
2 ARGX
Argenx SE
 930,548 $863,334,513
3 REGN
Regeneron Pharmaceuticals, Inc.
 1,270,087 $791,950,042
4 RVMD
Revolution Medicines, Inc.
 3,843,415 $719,794,757
5 ALNY
Alnylam Pharmaceuticals, Inc.
 2,110,407 $635,295,816
6 IONS
Ionis Pharmaceuticals Inc
 7,651,415 $606,680,693
7 CYTK
Cytokinetics Inc
 6,931,770 $590,517,483
8 MDGL
Madrigal Pharmaceuticals, Inc.
 825,714 $443,367,129

All Filings in ZYME

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,875,765 110,014
2026-03-31 $3,472,796 138,690
2025-12-31 $4,784,291 181,705
2025-09-30 $2,881,138 168,685
2025-06-30 $2,267,658 180,690
2025-03-31 $2,170,549 182,246
2024-12-31 $3,207,594 219,098
2024-09-30 $3,052,021 243,189
2024-06-30 $2,848,985 334,781
2024-03-31 $3,014,977 286,595
2023-12-31 $2,132,505 205,246
2023-09-30 $993,363 156,682
2023-06-30 $487,105 56,378